IDEX Corp (IEX): Evaluating Valuation After Earnings Beat, Growth Guidance, and Portfolio Optimization

IDEX (IEX) posted stronger-than-expected earnings for the latest quarter, with organic growth from its Health and Science Technologies segment and contributions from the Intelligent Water platform catching the spotlight for investors.

See our latest analysis for IDEX.

Shares of IDEX have had a challenging year, reflected in a one-year total shareholder return of -20.5% as broader market volatility and sector-specific pressures weighed on sentiment. While the recent earnings beat, revised guidance, and a completed buyback program have helped steady the share price, which is up 5.9% over the past 90 days, long-term investors remain watchful, weighing the company’s operational tweaks and growth focus against a difficult backdrop.

If IDEX’s recent moves have you thinking bigger, it could be the perfect moment to broaden your search and discover fast growing stocks with high insider ownership

After a turbulent year for IDEX, the improved outlook and analyst optimism prompt a key question for investors: does the current price offer room for meaningful upside, or is future growth already reflected in the valuation?

Most Popular Narrative: 11.9% Undervalued

With IDEX’s consensus fair value sitting at $194.62 per share against a last close of $171.46, the most widely followed narrative points to meaningful upside from current levels, banking on projections for margin improvement and revenue expansion over the next few years.

“Strong growth is expected in the space, defense, and energy transition sectors, which are key areas for IDEX. This is likely to drive revenue increases as these sectors expand and demand for IDEX’s solutions grows.”

Read the complete narrative.

Want to know the earnings and margin forecast that back this price target? The main driver of this narrative hinges on bold projections for both top and bottom-line growth. These are numbers you won’t find in the headlines. Curious which sector surges and profit assumptions are baked in? See what sets this narrative apart and shapes the valuation story.

Result: Fair Value of $194.62 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, ongoing policy uncertainty and sector-specific slowdowns remain notable risks. These factors could undermine IDEX’s projected growth and limit valuation upside.

Find out about the key risks to this IDEX narrative.

Another View: Comparing Price-to-Earnings

Looking from a different angle, IDEX trades at a price-to-earnings ratio of 26.8x, which is higher than both its US Machinery industry peers (23.5x) and its own fair ratio of 25.4x. This premium suggests investors are paying up for future growth, which introduces added valuation risk if projections don’t play out as expected. Could the market be too optimistic, or is IDEX worth the stretch?

See what the numbers say about this price — find out in our valuation breakdown.

Build Your Own IDEX Narrative

If you’re seeing the story differently or want to dig deeper into the numbers, you can craft your own data-backed view in just a few minutes. Do it your way

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding IDEX.

Looking for more investment ideas?

If you want an edge, now is the time to expand your search and discover opportunities others might miss. Simply Wall Street’s screener unveils hidden gems every day.

• Unlock consistent potential by targeting stable income with these 20 dividend stocks with yields > 3% yielding more than 3% from companies committed to rewarding shareholders.
• Accelerate your portfolio’s growth by connecting with these 27 AI penny stocks expected to power the next wave of innovation in artificial intelligence.
• Position yourself at the forefront of finance by tapping into these 81 cryptocurrency and blockchain stocks driving blockchain adoption and digital transformation across global markets.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com